Weight-loss jabs could prevent and treat addiction to alcohol, cigarettes and drugs, according to a large study. Experts ...
Jabs like Wegovy and Ozempic may cut the risk of life-threatening complications after a heart attack, researchers have ...
A new study reports that GLP-1 semaglutide medications may help reverse the effects of osteoarthritis in the joints by ...
Monthly costs for Ozempic and Wegovy will decrease to $675 in 2027, matching price adjustments scheduled for federal Medicare programs.
Downside to dropping pounds? The new pill form of popular GLP-1 drugs contains a compound that could cause troubling side ...
A few months into GLP-1 treatment, many patients encounter an unexpected and distressing side effect: significant hair loss.
Novo Nordisk announced up to 50% price cuts for Ozempic and Wegovy diabetes and weight-loss drugs starting January 2027, ...
New research has found that people taking medications such as Mounjaro or Wegovy for weight loss purposes may regain the majority of the weight they lost when they stop taking it. The jabs, also known ...
Novo Nordisk will cut prices of the diabetes and weight loss drugs Ozempic, Rybelsus and Wegovy to $675 effective Jan. 1, 2027.
Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...
The price of the popular GLP-1 medications will be cut, starting in January of 2027, manufacturer Novo Nordisk said in a ...
Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results